特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
361449

世界の止血剤・組織シーラント市場:2020年~2024年の予測

Global Hemostats and Tissue Sealants Market 2020-2024

出版日: | 発行: TechNavio (Infiniti Research Ltd.) | ページ情報: 英文 157 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.60円
世界の止血剤・組織シーラント市場:2020年~2024年の予測
出版日: 2020年01月02日
発行: TechNavio (Infiniti Research Ltd.)
ページ情報: 英文 157 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の止血剤・組織シーラント市場は、予測期間中に5%のCAGRで成長する見通しで、2024年に9億2,195万米ドルに達すると予測されています。同市場の成長は、手術における止血剤・組織シーラントの使用によって推進されています。また、新しい止血剤・組織シーラントの研究開発の増加は、同市場の成長を後押しすると期待されています。

当レポートは世界の止血剤・組織シーラント市場について調査しており、市場成長要因、動向や課題、製品・地域別の市場分析、ベンダー情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 レポートの範囲

  • 序文
  • 米ドルの為替レート

第3章 市場状況

  • 市場エコシステム
  • 市場の特徴
  • 市場セグメンテーション分析
  • バリューチェーン分析

第4章 市場規模

  • 市場の定義
  • 2019年の市場規模
  • 市場の見通し
  • 市場規模と予測:2019-2024

第5章 ポーターのファイブフォース分析

  • バイヤーの交渉力
  • サプライヤーの交渉力
  • 新規参入の脅威
  • 代替品の脅威
  • ライバルの脅威
  • 市況

第6章 市場分析:製品別

  • 市場セグメンテーション
  • 比較
  • 止血剤
  • 組織シーラント・接着剤
  • フィブリンシーラント
  • 市場機会

第7章 顧客情勢

第8章 市場分析:地域別

  • 市場セグメンテーション
  • 比較
  • 北米
  • 欧州
  • アジア
  • その他の地域
  • 主要国
  • 市場機会

第9章 思考の枠組み

第10章 成長要因と課題

  • 市場成長要因
  • 市場の課題

第11章 市場動向

  • 戦略的な協業・買収
  • 新たな止血剤・組織シーラントに焦点を合わせた研究開発
  • 新興国での高い成長性

第12章 ベンダー情勢

  • 概要
  • 情勢の革新
  • 競合シナリオ

第13章 企業プロファイル

  • 対象ベンダー
  • ベンダー分類
  • ベンダーの市場での位置づけ
  • Advanced Medical Solutions Group Plc
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Co.
  • CryoLife Inc.
  • Integra LifeSciences Holdings Corp.
  • Johnson & Johnson Services Inc.
  • Medtronic Plc
  • Pfizer Inc.
  • Teleflex Inc.

第14章 付録

  • 調査方法
  • 略語のリスト
  • ベンダーの市場での位置づけの定義

第15章 TECHNAVIOについて

図表

LIST OF EXHIBITS:

  • Exhibit 01: Global healthcare equipment market
  • Exhibit 02: Segments of global healthcare equipment market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Vendors: Key offerings
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2019
  • Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
  • Exhibit 10: Five forces analysis 2019
  • Exhibit 11: Five forces analysis 2024
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2019
  • Exhibit 18: Product - Market share 2019-2024 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: Hemostats - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 21: Hemostats - Year-over-year growth 2020-2024 (%)
  • Exhibit 22: Tissue sealants and adhesives - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 23: Tissue sealants and adhesives - Year-over-year growth 2020-2024 (%)
  • Exhibit 24: Fibrin sealants - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 25: Fibrin sealants - Year-over-year growth 2020-2024 (%)
  • Exhibit 26: Market opportunity by product
  • Exhibit 27: Customer landscape
  • Exhibit 28: Market share by geography 2019-2024 (%)
  • Exhibit 29: Geographic comparison
  • Exhibit 30: North America - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 31: North America - Year-over-year growth 2020-2024 (%)
  • Exhibit 32: Increase in the number of various laparoscopic surgical procedures in European countries
  • Exhibit 33: Number of people aged 65 years and above in EU and countries in 2005 and 2018 (in millions)
  • Exhibit 34: Europe - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 35: Europe - Year-over-year growth 2020-2024 (%)
  • Exhibit 36: Number of people aged 65 years and above in Asian countries in 2005 and 2018 (in millions)
  • Exhibit 37: Asia - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 38: Asia - Year-over-year growth 2020-2024 (%)
  • Exhibit 39: ROW - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 40: ROW - Year-over-year growth 2020-2024 (%)
  • Exhibit 41: Key leading countries
  • Exhibit 42: Market opportunity
  • Exhibit 43: Impact of drivers and challenges
  • Exhibit 44: Vendor landscape
  • Exhibit 45: Landscape disruption
  • Exhibit 46: Vendors covered
  • Exhibit 47: Vendor classification
  • Exhibit 48: Market positioning of vendors
  • Exhibit 49: Advanced Medical Solutions Group Plc - Vendor overview
  • Exhibit 50: Advanced Medical Solutions Group Plc - Business segments
  • Exhibit 51: Advanced Medical Solutions Group Plc - Organizational developments
  • Exhibit 52: Advanced Medical Solutions Group Plc - Geographic focus
  • Exhibit 53: Advanced Medical Solutions Group Plc - Segment focus
  • Exhibit 54: Advanced Medical Solutions Group Plc - Key offerings
  • Exhibit 55: B. Braun Melsungen AG - Vendor overview
  • Exhibit 56: B. Braun Melsungen AG - Business segments
  • Exhibit 57: B. Braun Melsungen AG - Organizational developments
  • Exhibit 58: B. Braun Melsungen AG - Geographic focus
  • Exhibit 59: B. Braun Melsungen AG - Segment focus
  • Exhibit 60: B. Braun Melsungen AG - Key offerings
  • Exhibit 61: Baxter International Inc. - Vendor overview
  • Exhibit 62: Baxter International Inc. - Business segments
  • Exhibit 63: Baxter International Inc. - Organizational developments
  • Exhibit 64: Baxter International Inc. - Geographic focus
  • Exhibit 65: Baxter International Inc. - Segment focus
  • Exhibit 66: Baxter International Inc. - Key offerings
  • Exhibit 67: Becton, Dickinson and Co. - Vendor overview
  • Exhibit 68: Becton, Dickinson and Co. - Business segments
  • Exhibit 69: Becton, Dickinson and Co. - Organizational developments
  • Exhibit 70: Becton, Dickinson and Co. - Geographic focus
  • Exhibit 71: Becton, Dickinson and Co. - Segment focus
  • Exhibit 72: Becton, Dickinson and Co. - Key offerings
  • Exhibit 73: CryoLife Inc. - Vendor overview
  • Exhibit 74: CryoLife Inc. - Business segments
  • Exhibit 75: CryoLife Inc. - Organizational developments
  • Exhibit 76: CryoLife Inc. - Geographic focus
  • Exhibit 77: CryoLife Inc. - Segment focus
  • Exhibit 78: CryoLife Inc. - Key offerings
  • Exhibit 79: Integra LifeSciences Holdings Corp. - Vendor overview
  • Exhibit 80: Integra LifeSciences Holdings Corp. - Business segments
  • Exhibit 81: Integra LifeSciences Holdings Corp. - Organizational developments
  • Exhibit 82: Integra LifeSciences Holdings Corp. - Geographic focus
  • Exhibit 83: Integra LifeSciences Holdings Corp. - Segment focus
  • Exhibit 84: Integra LifeSciences Holdings Corp. - Key offerings
  • Exhibit 85: Johnson & Johnson Services, Inc. - Vendor overview
  • Exhibit 86: Johnson & Johnson Services, Inc. - Business segments
  • Exhibit 87: Johnson & Johnson Services, Inc. - Organizational developments
  • Exhibit 88: Johnson & Johnson Services, Inc. - Geographic focus
  • Exhibit 89: Johnson & Johnson Services, Inc. - Segment focus
  • Exhibit 90: Johnson & Johnson Services, Inc. - Key offerings
  • Exhibit 91: Medtronic Plc - Vendor overview
  • Exhibit 92: Medtronic Plc - Business segments
  • Exhibit 93: Medtronic Plc - Organizational developments
  • Exhibit 94: Medtronic Plc - Geographic focus
  • Exhibit 95: Medtronic Plc - Segment focus
  • Exhibit 96: Medtronic Plc - Key offerings
  • Exhibit 97: Pfizer Inc. - Vendor overview
  • Exhibit 98: Pfizer Inc. - Business segments
  • Exhibit 99: Pfizer Inc. - Organizational developments
  • Exhibit 100: Pfizer Inc. - Geographic focus
  • Exhibit 101: Pfizer Inc. - Segment focus
  • Exhibit 102: Pfizer Inc. - Key offerings
  • Exhibit 103: Teleflex Inc. - Vendor overview
  • Exhibit 104: Teleflex Inc. - Business segments
  • Exhibit 105: Teleflex Inc. - Organizational developments
  • Exhibit 106: Teleflex Inc. - Geographic focus
  • Exhibit 107: Teleflex Inc. - Segment focus
  • Exhibit 108: Teleflex Inc. - Key offerings
  • Exhibit 109: Validation techniques employed for market sizing
  • Exhibit 110: Definition of market positioning of vendors
目次
Product Code: IRTNTR40802

Technavio has been monitoring the global hemostats and tissue sealants market and it is poised to grow by USD 921.95 mn during 2020-2024, progressing at a CAGR of 5% during the forecast period. Our reports on global hemostats and tissue sealants market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by use of hemostats and tissue sealants in surgeries.In addition, increasing r&d on novel hemostats and tissue sealants is anticipated to boost the growth of the global hemostats and tissue sealants market as well.

Market Segmentation

Technavio's global hemostats and tissue sealants market is segmented as below:

Product:

  • Hemostats
  • Tissue Sealants And Adhesives
  • Fibrin Sealants

Geographic segmentation

  • Asia
  • Europe
  • North America
  • ROW

Key Trends for global hemostats and tissue sealants market growth

This study identifies increasing r&d on novel hemostats and tissue sealants as the prime reasons driving the global hemostats and tissue sealants market growth during the next few years.

Prominent vendors in global hemostats and tissue sealants market

We provide a detailed analysis of around 25 vendors operating in the global hemostats and tissue sealants market , including some of the vendors such as Advanced Medical Solutions Group Plc, B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Co., CryoLife Inc., Integra LifeSciences Holdings Corp., Johnson & Johnson Services Inc., Medtronic Plc, Pfizer Inc. and Teleflex Inc. .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
  • Value chain analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2019
  • Market Outlook
  • Market size and forecast 2019-2024

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Hemostats - Market size and forecast 2019-2024
  • Tissue sealants and adhesives - Market size and forecast 2019-2024
  • Fibrin sealants - Market size and forecast 2019-2024
  • Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Strategic collaborations and acquisitions
  • Increasing R&D focus on novel hemostats and tissue sealants
  • High growth potential in emerging countries

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Advanced Medical Solutions Group Plc
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Co.
  • CryoLife Inc.
  • Integra LifeSciences Holdings Corp.
  • Johnson & Johnson Services Inc.
  • Medtronic Plc
  • Pfizer Inc.
  • Teleflex Inc.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.